Sixty-nine unselected SLE patients were studied to evaluate the prevalence of avascular osteonecrosis (AVN) and its relationship with steroid therapy and with anticardiolipin antibodies (aCL). All the patients were under treatment with corticosteroids. AVN occurred in seven of the 69 patients (10. 14%) and was not related to corticosteroid intake. Seventeen of the 69 patients were also treated with methylprednisolone pulse therapy (MPPT) and cumulated the highest corticosteroid doses but none of them suffered from AVN. Excluding the 17 MPPT-treated SLE patients, corticosteroid intake was significantly higher in the AVN-SLE patients.
Abnormal IgG and/or IgM aCL serum levels were found in two of the seven AVN-SLE patients and in 24 of the 62 non-AVN SLE, without a statistically significant difference. None of the seven AVN-SLE patients showed features of antiphospholipid syndrome.
We conclude that in SLE patients a continuous high-dose steroid treatment may be considered a risk factor for AVN. On the contrary, MPPT regimen may reduce this risk. Anticardiolipin antibodies might represent an added factor which could play a role in some patients but not in all.
Asherson RA, Lioté F., Page B. et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol1993; 20: 284-8.
2.
Bergstein JM , Wiens C., Fish AJ, Vernier RL, Michael A.Avascular necrosis of bone in systemic lupus erythematosus. J Pediatr1974; 85: 31-5.
3.
Dubois EL, Cozen L.Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus . JAMA1960; 174: 966-84.
4.
Dubois EL, Tuffanelli DLClinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA1964; 190: 104-11.
5.
Zizic TM, Marcouz C., Hungerford DS, Dansereau J-Y., Stevens MBCorticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med1985 ; 79: 596-604.
6.
Harrington KD , Murray WR, Kountz SL, Belzer FOAvascular necrosis of bone after renal transplantation . J Bone Joint Surg1971; 53: 203-15.
7.
Asherson RA, Jungers P., Lioté F. et al. Ischaemic necrosis of bone associated with the 'lupus anticoagulant' and antibodies to cardiolipin. Proceedings of XVIth International Congress of Rheumatology, Sydney, Australia, May 1985, p. 373.
8.
Nagasawa K., Ishii Y., Mayumi T.Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis1989; 48: 672-6.
9.
Abeles M., Weiner ES, Parke A., Wilson D.The association of osteonecrosis in SLE with anticardiolipin antibodies . Arthritis Rheum1991; 34(Suppl.): R39.
10.
Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271-7.
11.
Tirri G., Migliaresi S., Picillo U., Improta R., Tirri R., Giordano M.Methylprednisolone pulse therapy for systemic lupus erythematosus (a study of 11 cases). Conn Tissue Dis1983 ; 2: 107-21.
Gharavi AE, Harris EN, Asherson RA, Hughes Grv.Anticardiolipin antibodies: isotype distribution and phospholipid specificity . Ann Rheum Dis1987; 46: 1-6.
14.
Picillo U., Migliaresi S., Marcialis MR, Longobardo A., La Palombara F, Tirri G.Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationship with clinical manifestations and disease activity in an Italian series. Scand J Rheumatol1992 ; 21: 271-6.
Hurley RM, Steinberg RH, Patriquin H., Drummond KNAvascular necrosis of the femoral head in childhood systemic lupus erythematosus . Can Med Ass J1974; 11: 781-4.
17.
Weiner ES, Abeles M.Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a re-evaluation. J Rheumatol1989 ; 16: 604-8.
18.
Hochberg MC , Boyd RE, Ahearn JM et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine1985; 64: 285-95.
19.
Beltran J., Herman LJ, Burk JM et al. Femoral head avascular necrosis: MR imaging with clinical-pathologic and radionuclide correlation. Radiology1988 ; 166: 215-20.
20.
Genez BM, Wilson MR, Houk RW et al. Early osteonecrosis of the femoral head: detection in high-risk patients with MR imaging. Radiology1988; 168: 521-4.
21.
Kalunian KC , Hahn BH, Basset L.Magnetic resonance imaging identifies early femoral head ischemic necrosis in patients receiving glucocortidoid therapy . J Rheumatol1989 ; 16: 959-63.
22.
Robinson HJ , Hartleben PD, Lund G., Schreiman J.Evaluation of magnetic resonance imaging in the diagnosis of osteonecrosis of the femoral head. Accuracy compared with radiographs, core biopsy and intraosseus pressure measurements. J Bone Joint Surg1989; 71: 650-63.
23.
Stulberg BN , Levine M., Bauer TW et al. Multimodality approach to osteonecrosis of the femoral head. Clin Orthop1989; 240: 181-93.
24.
Tervonen O. , Mueller DM, Matteson EL, Velosa JA, Ginzburg WW, Ehman RLClinically occult avascular necrosis of the hip: prevalence in an asymptomatic population at risk. Radiology1992; 182: 845-7.
25.
Stolow J., Parikh S., Shybut G., Robinson P., Pope RMAn atypical site of osteonecrosis in a patient with systemic lupus erythematosus . J Rheumatol1991 ; 18: 1623-6.
26.
Urman JD, Abeles M., Houghton AN, Rothfield N.Aseptic necrosis presenting as wrist pain in SLE. Arthritis Rheum1977; 20: 825-8.
27.
Fishel B., Caspi D., Eventov I., Avrahami E., Yaron M.Multiple osteonecrotic lesions in systemic lupus erythematosus. J Rheumatol1987; 14: 601-4.
28.
Mankin HJNontraumatic necrosis of bone (osteonecrosis). New Engl J Med1992; 326: 1473-9.
29.
Watanabe J. , Kawai K., Hirohata K.Histopathology of femoral head osteonecrosis in rheumatoid arthritis: the relationship between steroid therapy and lipid degeneration in the osteocyte. Rheumatol Int1989; 9: 25-31.
30.
De Graaf P, van Hooff JP, Boekhout M., Achterberg J., Pauwels Ekj, Kalff MWHyperparathyroidism and avascular necrosis of bone after kidney transplantation. Neth J Med1982; 25: 230-6.
31.
Williams IA , Mitchell AD, Rothman W., Tallet P., Williams K., Pitt P.Survey of the long-term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone. Ann Rheum Dis1988; 47: 930-3.
32.
Felson DT, Anderson JJAcross-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet1987 ; 1: 902-5.
33.
Boumpas DT, Austin HA, Vaughn EM et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet1992; 340: 741-5.
34.
Ono K., Tohjima T., Komazawa T.Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy. Clin Orthop1992; 277: 89-97.
35.
Klipper AR, Stevens MB, Zizic TM, Hungerford DSIschemic necrosis of bone in systemic lupus erythematosus. Medicine1976; 55: 251-7.
36.
Edwards RL, Rickles FRThe role of leukocytes in the activation of blood coagulation. Semin Hematol1992; 29: 202-12.
37.
Jones JPIntravascular coagulation and osteonecrosis. Clin Orthop1992; 277: 41-53.
38.
Schved JF, Gris JC, Ollivier V., Wautier JL, Tobelem G., Caen J.Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulant. Am J Hematol1992 ; 41: 92-6.
39.
Asherson RA , Khamashta MA, Ordi-Ros J. et al. The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine1989; 68: 366-74.
40.
Seleznic MJ , Silveira LH, Espinoza LRAvascular necrosis associated with anticardiolipin antibodies. J. Rheumatol1991; 18: 1416-17.
